Enlivex Therapeutics Ltd. (TLV:ENLV)
556.30
-18.20 (-3.17%)
Aug 14, 2025, 5:24 PM IDT
Enlivex Therapeutics Market Cap
Enlivex Therapeutics has a market cap or net worth of 125.05 million as of August 14, 2025. Its market cap has increased by 17.57% in one year.
Market Cap
125.05M
Enterprise Value
57.20M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
556.30
Market Cap Chart
Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 125.05M, a decrease of -66.02%. That is a compound annual growth rate of -15.55%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 64.35B |
Danel (Adir Yeoshua) | 2.50B |
Kamada | 1.44B |
Bait Bakfar | 1.05B |
SofWave Medical | 977.04M |
BrainsWay | 772.64M |
Novolog (Pharm-Up 1966) | 709.61M |
Ilex Medical | 675.99M |